A Falahati

444 total citations
23 papers, 344 citations indexed

About

A Falahati is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, A Falahati has authored 23 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in A Falahati's work include Diabetes Treatment and Management (14 papers), Metabolism, Diabetes, and Cancer (8 papers) and Diabetes Management and Research (6 papers). A Falahati is often cited by papers focused on Diabetes Treatment and Management (14 papers), Metabolism, Diabetes, and Cancer (8 papers) and Diabetes Management and Research (6 papers). A Falahati collaborates with scholars based in Denmark, United States and United Kingdom. A Falahati's co-authors include Jason Brett, Jaime A. Davidson, David A. Scott, Sten Madsbad, Allan Vaag, Richard E. Pratley, Anders Toft, Baptist Gallwitz, Adam Steensberg and Bruce W. Bode and has published in prestigious journals such as Diabetes, Gut and Diabetologia.

In The Last Decade

A Falahati

22 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Falahati Denmark 9 246 129 88 64 39 23 344
Antonio Rossi Italy 11 220 0.9× 94 0.7× 106 1.2× 45 0.7× 111 2.8× 29 442
Katherine A. Hughes United Kingdom 9 279 1.1× 46 0.4× 45 0.5× 43 0.7× 56 1.4× 14 358
Katarzyna Musialik Poland 13 84 0.3× 78 0.6× 40 0.5× 36 0.6× 94 2.4× 29 341
Chin Meng Khoo Singapore 12 172 0.7× 106 0.8× 58 0.7× 18 0.3× 106 2.7× 20 362
Jinous Samavat Italy 9 160 0.7× 61 0.5× 69 0.8× 79 1.2× 55 1.4× 16 354
Silvia Burlina Italy 8 260 1.1× 67 0.5× 76 0.9× 10 0.2× 53 1.4× 12 430
Zelija Velija-Ašimi Bosnia and Herzegovina 12 161 0.7× 86 0.7× 53 0.6× 19 0.3× 52 1.3× 39 378
CA Stuart United States 4 230 0.9× 92 0.7× 53 0.6× 25 0.4× 97 2.5× 6 378
Christina Gar Germany 10 121 0.5× 102 0.8× 74 0.8× 19 0.3× 88 2.3× 21 322
Motoyuki Tamaki Japan 10 141 0.6× 101 0.8× 168 1.9× 41 0.6× 158 4.1× 25 456

Countries citing papers authored by A Falahati

Since Specialization
Citations

This map shows the geographic impact of A Falahati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Falahati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Falahati more than expected).

Fields of papers citing papers by A Falahati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Falahati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Falahati. The network helps show where A Falahati may publish in the future.

Co-authorship network of co-authors of A Falahati

This figure shows the co-authorship network connecting the top 25 collaborators of A Falahati. A scholar is included among the top collaborators of A Falahati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Falahati. A Falahati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lobo, R, A Falahati, Kelle H. Moley, et al.. (2024). Oocyte yield and live birth rate after follitropin delta dosing and fresh embryo transfer: an individual patient data meta-analysis. Reproductive BioMedicine Online. 50(2). 104451–104451. 1 indexed citations
3.
4.
Falahati, A, et al.. (2020). Spatiotemporal expression of activin receptor-like kinase-5 and bone morphogenetic protein receptor type II in the ovary of shortfinned eel, Anguilla australis. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 251. 110509–110509. 4 indexed citations
5.
6.
Ataee, Ramin, et al.. (2016). Anticonvulsant activities of Sambucus nigra.. PubMed. 20(14). 3123–6. 16 indexed citations
7.
Bode, Bruce W., Jason Brett, A Falahati, & Richard E. Pratley. (2011). Comparison of the Efficacy and Tolerability Profile of Liraglutide, a Once-Daily Human GLP-1 Analog, in Patients With Type 2 Diabetes ≥65 and <65 Years of Age: A Pooled Analysis from Phase III Studies. ˜The œAmerican journal of geriatric pharmacotherapy. 9(6). 423–433. 48 indexed citations
8.
Davidson, Jaime A., Jason Brett, A Falahati, & David A. Scott. (2011). Mild Renal Impairment and the Efficacy and Safety of Liraglutide. Endocrine Practice. 17(3). 345–355. 24 indexed citations
9.
García-Hernández, Pedro Alberto, et al.. (2011). [Liraglutide and glimepiride on glycaemic control in type 2 diabetes in the Mexican cohort (LEAD 3)].. PubMed. 48(5). 543–8. 2 indexed citations
10.
Gough, Stephen, Sten Madsbad, Klaus H. Jensen, A Falahati, & S. Bain. (2010). Liraglutide Is Associated with Reduced Rates of Hypoglycemic Events Versus Glimepiride When Achieving Target HbA(1c). Diabetes. 59. 1 indexed citations
11.
Armstrong, Matthew J., et al.. (2010). High prevalence of advanced NAFLD in type 2 diabetic patients with unremarkable liver enzymes and effect of liraglutide on NAFLD: meta-analysis of the LEAD Program. Diabetologia. 53. 1 indexed citations
12.
Armstrong, Matthew J., A Falahati, Oscar Ö. Braun, et al.. (2010). High Prevalence of Advanced NAFLD in Type 2 Diabetic Patients with Normal Liver Enzymes and Effect of Liraglutide on NAFLD: Meta-Analysis of the LEAD Program. Diabetes. 59. 4 indexed citations
13.
Toft, Anders, A Falahati, & Adam Steensberg. (2010). Source and kinetics of interleukin-6 in humans during exercise demonstrated by a minimally invasive model. European Journal of Applied Physiology. 111(7). 1351–1359. 37 indexed citations
14.
15.
Davidson, Jaime A., Jason Brett, A Falahati, & David A. Scott. (2010). Mild Renal Impairment and the Efficacy and Safety of Liraglutide. Endocrine Practice. 17(3). 345–355. 64 indexed citations
16.
Zinman, Bernard, John B. Buse, A Falahati, A C Moses, & S Gough. (2009). Liraglutide More Effectively Achieves a Composite Endpoint for A1C, SBP and Weight Change Than Other Diabetes Therapies. Diabetes. 58. 8 indexed citations
17.
Schmidt, Wolfgang E., Stephen Gough, Sten Madsbad, et al.. (2009). Liraglutide, a human GLP-1 analogue, lowers HbA(1c) independent of weight loss. Diabetologia. 52. 5 indexed citations
18.
Gallwitz, Baptist, Allan Vaag, A Falahati, & Sten Madsbad. (2009). Adding liraglutide to oral antidiabetic drug therapy: onset of treatment effects over time. International Journal of Clinical Practice. 64(2). 267–276. 50 indexed citations
19.
Plutzky, Jorge, et al.. (2009). Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis. Canadian Journal of Diabetes. 33(3). 209–210. 27 indexed citations
20.
Fonseca, Vivian, A Falahati, Marcin Zychma, Sten Madsbad, & Jorge Plutzky. (2009). Liraglutide, a once-daily human GLP-1 analogue, reduces systolic blood pressure within 2 weeks in patients with type 2 diabetes. Canadian Journal of Diabetes. 33(3). 255–256. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Rossi Breakdown of academic impact, for papers by Katherine A. Hughes Breakdown of academic impact, for papers by Katarzyna Musialik Breakdown of academic impact, for papers by Chin Meng Khoo Breakdown of academic impact, for papers by Jinous Samavat Breakdown of academic impact, for papers by Silvia Burlina Breakdown of academic impact, for papers by Zelija Velija-Ašimi Breakdown of academic impact, for papers by CA Stuart Breakdown of academic impact, for papers by Christina Gar Breakdown of academic impact, for papers by Motoyuki Tamaki
Rankless by CCL
2026